As of November 6, 2026, Biophytis SA has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 2 filings are on record since October 17, 2025 (Schedule 13G/A, January 21, 2026).
Sell to companies like Biophytis SA? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Biophytis SA has 2 Schedule 13D or 13G filings on record since 2025-10-17. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 4.8% | 1,905,946 | SCHEDULE 13G/A, 2026-01-21 | 2025-12-31 |
Holding shares or following this stake? See who's behind Biophytis SA and the warning signs.
Free to see. No signup.
Keep reading
More on Biophytis SA and the records around it.
Biophytis SA elsewhere on the record
- Company profile and every filing Sep 2026
- Form D filing Sep 2026
- Form D filing Mar 2026
Companies that share a holder
- BlackRock Portfolio Management LLC also filed stake reports on 118 other companies: AMERISAFE INC (Nov 2026), BlackRock ETF Trust (Nov 2026), iShares J.P. Morgan EM Local Currency Bond ETF (Nov 2026)
Watch Biophytis SA
Get an email when Biophytis SA files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Biophytis SA?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Biophytis SA: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biophytis SA covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-17 | BlackRock Portfolio Management LLC | 5.2% | SCHEDULE 13G |
| 2026-01-21 | BlackRock Portfolio Management LLC | 4.8% | SCHEDULE 13G/A |
Also on the record for Biophytis SA
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 23, 2026 | Form D, private offering | $2.60M sold | Form D page | Source |
| March 23, 2026 | Form D, private offering | $1.58M sold | Form D page | Source |
Biophytis SA: every filing and event
Tools for this story
Each opens in a new tab, filled in for Biophytis SA. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.